Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00425_DB00705_nanopub.RAd_eH_2U5qKgpnTptUZPwAI3X6Wx7o7qhMwzb-8EKHFQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00425_DB00705 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00425_DB00705 label "DDI between Zolpidem and Delavirdine - Delavirdine, a strong CYP3A4 inhibitor, may increase the serum concentration of zolpidem by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zolpidem if delavirdine is initiated, discontinued or dose changed. [drugbank_resource:DB00425_DB00705]" assertion.
- drugbank_resource:DB00425_DB00705 identifier "drugbank_resource:DB00425_DB00705" assertion.
- drugbank_resource:DB00425_DB00705 title "DDI between Zolpidem and Delavirdine - Delavirdine, a strong CYP3A4 inhibitor, may increase the serum concentration of zolpidem by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zolpidem if delavirdine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00425 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00425_DB00705 assertion.
- drugbank:DB00705 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00425_DB00705 assertion.